Roche Says to Pull Older HIV Drug on Poor Demand
May 19, 2005
On Wednesday, Swiss drug maker Roche Holding AG said it will voluntarily discontinue its HIV drug Fortovase because of declining demand for the medicine. Due to the availability of Invirase -- a new formulation of the drug, which is better tolerated -- Roche will stop selling Fortovase in the first quarter of 2006. The decision was not based on concerns about the safety or efficacy of Fortovase, Roche said.
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.